Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats

Experimental Nephrology

Volumn 4, Issue 1, 1996, Pages 19-25

  Remuzzi, Andrea ^a   Malanchini, Barbara ^a   Battaglia, Cristina ^a   Bertani, Tullio ^a,b   Remuzzi, Giuseppe ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

Angiotensin; Angiotensin receptor antagonist; Angiotensin converting enzyme; MWF Ztm; Proteinuria; Renal hemodynamics

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; UNCLASSIFIED DRUG; ZD 7155;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HYPERTENSION; KIDNEY BLOOD FLOW; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; HYPERTENSION, RENAL; LISINOPRIL; MALE; NAPHTHYRIDINES; PROTEINURIA; RATS; RECEPTORS, ANGIOTENSIN; RENAL PLASMA FLOW;

EID: 0030071327     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986;77:1993-2000.
2. Anderson S, Diamond JR, Karnovsky MJ, Brenner BM: Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J Clin Invest 1988;82:1757-1768.
3. Yoshida Y, Kawamura T, Ikoma M, Fogo A, Ichikawa I: Effects of antihypertensive drugs on glomerular morphology. Kidney Int 1989; 36:626-635.
4. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 1990;85: 541-549.
5. Ikoma M, Kawamura T, Kakinuma Y, Fogo A, Ichikawa I: Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int 1991;40: 195-202.
6. de Zeeuw D, Heeg JE, de Jong PE: The antiproteinuric affect of angiotensin converting enzyme inhibitors in human renal disease; in Andreucci VE, Fine LG (eds): International Yearbook of Nephrology. London, Springer, 1992, pp 95-113.
7. Tanaka R, Kon V, Yoshioka T, Ichikawa I, Fogo A: Angiotensin converting enzyme inhibitor modulates glomerular functional and structure by distinct mechanisms. Kidney Int 1994; 45:537-543.
8. Veniant M, Heudes D, Clozel JP, Bruneval P, Menard J: Calcium blockade versus ACE inhibition in clipped and undipped kidneys of 2K-1C rats. Kidney Int 1994;46:421-429.
9. Meyer TW, Anderson S, Rennke HG, Brenner BM: Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int 1987;31:752-759.
10. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D: Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition. Kidney Int 1991;40:734-741.
11. Kakinuma Y, Kawamura T, Bills T, Yoshida Y, Ichikawa I, Fogo A: Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int 1992;42:46-55.
12. Remuzzi A, Imberti O, Puntorieri S, Malanchini B, Macconi D, Magrini L, Bertani T, Remuzzi G: Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in the rat. Am J Physiol 1994;267:F1034-F1044.
13. Skidgel RA, Schulz WW, Tam LT, Erdos EG: Human renal angiotensin I converting enzyme and neutral endopeptidase. Kidney Int 1987; 20(suppl):45-46.
14. Hutchinson FN, Martin VI: Effects of modulation of renal kallikrein-kinin system in the nephrotic syndrome. Am J Physiol 1990;258: F1237-F1244.
15. Kon V, Fogo A, Ichikawa I: Bradykinin causes selective efferent arteriolar dilatation during angiotensin I converting enzyme inhibition. Kidney Int 1993;44:545-550.
16. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992;90:766-771.
17. Remuzzi A, Perico N, Amuchastegui CS, Malanchini B, Mazerska M, Battaglia C, Bertani T, Remuzzi G: Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol 1993;4:40-49.
18. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986;77:1925-1930.
19. Gansevoort RT, de Zeeuw D, de Jong PE: Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition. Kidney Int 1993;44:579-584.
20. Hutchinson FN, Webster SK: Effect of ANG II receptor antagonist on albuminuria and renal function in passive Heyman nephritis. Am J Physiol 1992;263:F311-F318.
21. Crary GS, Swan SK, O'Donnell MP, Kasiske BL, Katz SA, Keane WF: Angiotensin II receptor antagonist lowers blood pressure but does not reduce renal injury in obese Zucker rats (abstract). J Am Soc Nephrol 1994;5:941.
22. Remuzzi A, Puntorieri S, Mazzoleni A, Remuzzi G: Sex related difference in glomerular ultrafiltration and proteinuria in Munich-Wistar rats. Kidney Int 1988;34:481-486.
23. Deen WM, Robertson CR, Brenner BM: A model of glomerular ultrafiltration in the rat. Am J Physiol 1972;223:1178-1183.
24. Remuzzi A, Puntorieri S, Alfano M, Macconi D, Abbate M, Bertani T, Remuzzi G: Pathophysiological implications of proteinuria in a rat model of progressive glomerular injury. Lab Invest 1992;67:572-579.
25. Ene Iordache B, Imberti O, Foglieni C, Remuzzi G, Bertani T, Remuzzi A: Effects of angiotensin-converting enzyme inhibition on glomerular capillary wall ultrastructure in MWF/ Ztm rats. J Am Soc Nephrol 1994;5:1378-1384.
26. Ausiello DA, Kreisberg JI, Roy C, Karnovsky MJ: Contraction of cultured rat glomerular cells of apparent mesangial origin after stimulation with angiotensin II and arginine vasopressin. J Clin Invest 1980;65:754-760.
27. Kriz W, Elger M, Lemley KV, Sakai T: Structure of the glomerular mesangium: A biomechanical interpretation. Kidney Int 1990; 38(suppl 30):2-9.
28. Drumond MC, Deen WM: Structural determinants of glomerular hydraulic permeability. Am J Physiol 1994;266:F1-F12.